Who owns ALIGOS THERAPEUTICS INC?
- Ticker: ALGS
- CUSIP Number: 01626l204
Tip: Access positions for across all investors
Analyze quarterly positions in Aligos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aligos Therapeutics stock
Who bought or sold ALIGOS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Woodline Partners | 468k | $4.6M | -10% | Sep 2025 |
|
| Deep Track Capital | 444k | $4.4M | 0% | Sep 2025 |
|
| Alyeska Investment Group | 412k | $4.0M | 0% | Sep 2025 |
|
| Sio Capital Management | 336k | $3.3M | 0% | Sep 2025 |
|
| Readystate Asset Management | 203k | $2.0M | 48% | Sep 2025 |
|
| Vanguard Group | 172k | $1.7M | 23% | Sep 2025 |
|
| Adage Capital Partners GP | 140k | $1.4M | 0% | Sep 2025 |
|
| Baker Bros. Advisors | 83k | $814k | 0% | Sep 2025 |
|
| Hillhouse Capital Advisors | 76k | $747k | 0% | Sep 2025 |
|
| LPL Financial | 55k | $540k | 83% | Sep 2025 |
|
| Renaissance Technologies | 55k | $539k | 5% | Sep 2025 |
|
| Geode Capital Management | 47k | $462k | 38% | Sep 2025 |
|
| Two Sigma Investments | 39k | $382k | 223% | Sep 2025 |
|
| Squarepoint Ops | 31k | $299k | 64% | Sep 2025 |
|
| UBS Group | 16k | $159k | 490% | Sep 2025 |
|
| BlackRock | 13k | $128k | 0% | Sep 2025 |
|
| Citadel Advisors | 10k | $101k | -32% | Sep 2025 |
|
| Susquehanna International | 10k | $99k | 100% | Sep 2025 |
|
| NorthCrest Asset Manangement | 10k | $98k | 100% | Sep 2025 |
|
| Quest Partners | 6.8k | $66k | 14% | Sep 2025 |
|
| Morgan Stanley | 4.0k | $29k | 100% | Jun 2025 |
|
| Wells Fargo & Company | 3.2k | $31k | -77% | Sep 2025 |
|
| Golden State Wealth Management | 2.7k | $26k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 2.1k | $21k | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 1.0k | $9.8k | 100% | Sep 2025 |
|
| Global Retirement Partners | 800.00 | $7.8k | 100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 708.00 | $6.9k | 2623% | Sep 2025 |
|
| Tower Research Capital | 457.00 | $4.5k | -59% | Sep 2025 |
|
| SBI Securities | 26.00 | $255.000200 | 0% | Sep 2025 |
|
| Barclays | 15.00 | $147.000000 | 100% | Sep 2025 |
|
| Zrc Wealth Management | 4.00 | $40.000000 | 0% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 3.00 | $29.000100 | -100% | Sep 2025 |
|
Who sold out of Aligos Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tang Capital Management | Jun 2025 | 141k | $1.0M |
| Charles Schwab Investment Management | Jun 2025 | 25k | $183k |
| XTX Topco | Jun 2025 | 14k | $100k |
| Millennium Management | Jun 2025 | 12k | $89k |
| Acadian Asset Management | Jun 2025 | 3.9k | $28k |
| Raymond James Financial | Jun 2025 | 500.00 | $3.6k |
| Advisor Group Holdings | Jun 2025 | 220.00 | $1.6k |
| FMR | Jun 2025 | 10.00 | $72.000000 |